Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHOD FOR QUANTITATIVELY MEASURING COLLAGENASE

  • Read more about METHOD FOR QUANTITATIVELY MEASURING COLLAGENASE
Canada
2074507
Filed on 1991-01-25

METHOD FOR QUANTITATIVELY MEASURING COLLAGENASE

  • Read more about METHOD FOR QUANTITATIVELY MEASURING COLLAGENASE
Australia
73025/91
Filed on 1991-01-25

CO2-Independent Growth Medium for Maintenance and Propagation of Cells

  • Read more about CO2-Independent Growth Medium for Maintenance and Propagation of Cells
The Netherlands
91904443.8
Filed on 1991-01-22

CO2-Independent Growth Medium for Maintenance and Propagation of Cells

  • Read more about CO2-Independent Growth Medium for Maintenance and Propagation of Cells
Denmark
91904443.8
Filed on 1991-01-22

POLYPEPTIDE HAVING HUMAN MONOCYTE CHEMOTACTIC FACTOR ACTIVITY AND A DNA ENCODING SAID POLYPEPTIDE

  • Read more about POLYPEPTIDE HAVING HUMAN MONOCYTE CHEMOTACTIC FACTOR ACTIVITY AND A DNA ENCODING SAID POLYPEPTIDE
Belgium
90901711.3
Filed on 1990-01-02

Hepatocellular Carcinoma Oncogene

  • Read more about Hepatocellular Carcinoma Oncogene
Hong Kong
00100070.3
Filed on 1990-12-13

DNA SEGMENT ENCODING A GENE FOR A RECEPTOR RELATED TO THE EPIDERMAL GROWTH FACTOR RECEPTOR (erbB-3)

  • Read more about DNA SEGMENT ENCODING A GENE FOR A RECEPTOR RELATED TO THE EPIDERMAL GROWTH FACTOR RECEPTOR (erbB-3)
Liechtenstein
91900108.1
Filed on 1990-11-30

Production and Use of Human NM23 Protein and Antibodies Therefore

  • Read more about Production and Use of Human NM23 Protein and Antibodies Therefore
Canada
2067797
Filed on 1990-10-17

ANTI-HYPERTENSIVE COMPOSITIONS OF SECONDARY AMINE-NITRIC OXIDE ADDUCTS AND USE THEREOF

  • Read more about ANTI-HYPERTENSIVE COMPOSITIONS OF SECONDARY AMINE-NITRIC OXIDE ADDUCTS AND USE THEREOF
United Kingdom
90914997.3
Filed on 1990-09-07

EFFICIENT METHOD FOR IDENTIFIABLE EXPRESSION OF NONSELECTABLE GENES

  • Read more about EFFICIENT METHOD FOR IDENTIFIABLE EXPRESSION OF NONSELECTABLE GENES
Spain
90911172.6
Filed on 1990-06-22

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1312
  • Page 1313
  • Page 1314
  • Page 1315
  • Page 1316
  • Page 1317
  • Page 1318
  • Page 1319
  • Page 1320
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health